In order to explore the impact of gender, age, date of first injection, number of injections, dosage of omalizumab, complicated allergy, and serous total IgE(tIgE) level on the efficacy of omalizumab, participants were divided into several subgroups according to these parameters. Here, IGHE is linked to allergic disease.